LEXINGTON, Ky. (AP) - A University of Kentucky research center has received $6 million to study a controversial drug treatment for Parkinson's disease.
The funding came from the National Institutes of Health and the National Institute of Neurological Disorders and Stroke for study of the drug G-D-N-F (glial cell line-derived neurotrophic factor).
The university's Morris K. Udall Parkinson's Disease Research Center of Excellence will conduct the research. The drug was pulled from a U-K study last year when its producer, Amgen, said studies found that high doses caused brain damage in some monkeys.
The university said in a statement today that G-D-N-F has demonstrated the potential to halt and in some cases reverse Parkinson's, a brain disorder that causes tremors and stiffness in the body. The director of the Udall Center, Greg Gerhardt, said the center will conduct a five-year study of the drug, including its potential negative effects and how to fine-tune dosing to improve effectiveness.
(Copyright 2005 by The Associated Press. All Rights Reserved.)
Buckingham Palace is undergoing a 10-year renovation of the wiring, plumbing and heating. The project is revealing hidden treasures.Full Story >
Under the proposal taking shape, Democrats would agree to a three-week spending measure in return for a commitment from the Republican leadership in the Senate to address immigration policy and other pressing legislative matters in the coming weeks.Full Story >
Netanyahu thanked Pence for President Donald Trump's "historic" recognition of Jerusalem as the capital of Israel and lauded the American-Israeli alliance, which he said has "never been stronger."Full Story >